Concepedia

Shu Niu

SN

8

Publications

253

Citations

8

H-Index

2022

Active since

Affiliations

Hebei General Hospital(Current)

Hebei Medical University

First Hospital of Shijiazhuang

Shu Niu is an author at Hebei General Hospital specializing in fibrosis, functional genomics, and gene expression.

Top concepts

Publications per year

2022–2023

8

Publications

8

An Effective Glucagon-Like Peptide-1 Receptor Agonists, Semaglutide, Improves Sarcopenic Obesity in Obese Mice by Modulating Skeletal Muscle Metabolism

Qingjuan Ren, Shuchun Chen, Xing Chen et al. · Drug Design Development and Therapy · 2022 · 79 citations · Full text

Semaglutide ameliorates metabolism and hepatic outcomes in an NAFLD mouse model

Shu Niu, Shuchun Chen, Xing Chen et al. · Frontiers in Endocrinology · 2022 · 52 citations · Full text

Single-cell transcriptomics identifies Col1a1 and Col1a2 as hub genes in obesity-induced cardiac fibrosis

Xiaoyu Pan, Xing Chen, Qingjuan Ren et al. · Biochemical and Biophysical Research Communications · 2022 · 32 citations

, , +11

Effect of semaglutide and empagliflozin on cognitive function and hippocampal phosphoproteomic in obese mice

Xiaoyi Chen, Shuchun Chen, Zelin Li et al. · Frontiers in Pharmacology · 2023 · 26 citations · Full text

Effects of semaglutide on vascular structure and proteomics in high-fat diet-induced obese mice

Lin Yue, Shuchun Chen, Qingjuan Ren et al. · Frontiers in Endocrinology · 2022 · 22 citations · Full text

Rows per page

1–5 of 8